ArticleFrontiers in cellular neuroscience2016

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.

Yehezkel Ben-Ari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.